FOOD AND DRUG ADMINISTRATION

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

 

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

 

MEETING ON CBER LABORATORY SITE VISIT

LABORATORY OF ENTERIC AND SEXUALLY TRANSMITTED DISEASES

MEETING BY TELECONFERENCE

 

 NOVEMBER 18, 2002

BUILDING 29B, CONF. ROOM C

Bethesda, Maryland

1:00 PM EST

 

 

1:00 p.m.                    Call to Order                                                  Robert Daum, M.D.

                                                                                                            VRBPAC Chair

 

1:15  p.m.                   Announcements                                                 Jody Sachs, D.P.M.

                                                                                                            VRBPAC Exec. Sec., FDA

1:20  p.m.                   Open Session

                                    Overview of Division of Bacterial, Parasitic & Allergenic Products

                                                                                                           Richard Walker, Ph.D.

                                                                                                           Division Director, FDA   

                                  

1:30  p.m.                 Overview of Laboratory of Enteric and Sexually Transmitted Diseases (LESTD)

                                                                                                           Dennis Kopecko, Ph.D.

                                                                                                           Laboratory Chief, FDA

 

 1:40 p.m.                  Overview of Research Activities                    Scott Stibitz, Ph.D.

                                                                                                            LESTD, FDA

 

  1:50 p.m.                  Overview of Research Activities                    Philip Boucher, Ph.D.

                                                                                                            LESTD, FDA

 

  2:00 p.m.                  Open Public Hearing

 

  3:00 p.m.                 Closed Session

                                    Discussion and Committee Recommendations

 

  3:30 p.m.         Adjournment